A team at Huntsman Cancer Institute at the University of Utah (the U) has uncovered a previously unrecognized molecular ...

Continued site activation in registrational SAFEGUARD trial of SAB-142; enrollment ongoing and on track to be completed by end of 2026 with ...

Neion Bio uses genetically engineered chickens to produce therapeutic proteins in eggs, aiming for a drastic reduction in the ...

Julia Bauman creates engaging short-form TikTok videos that make science topics accessible to a broad audience.

A Moffitt Cancer Center researcher has introduced a new model that addresses one of biology's most fundamental questions: How does genetic information keep living systems organized and therefore alive ...

Oligodendrocyte biology is at the forefront of current neuroscience, with increasing recognition of the complex roles these glial cells play beyond ...

CAMBRIDGE, Mass., April 9, 2026 /PRNewswire/ -- Deck Bio today launches with a multi-target approach designed to expand the reach of T cell engagers in solid tumors by addressing tumor heterogeneity ...

The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to July 6. The review extension comes after the company submitted additional data ...

BERKELEY, CA, March 10, 2026 (EZ Newswire) -- R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived biological platforms ...

Orca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the commercialization of a blood cancer cell therapy. California-based Orca filed for FDA ...

New stem cell-based embryo model reveals previously unknown communication between early tissues that become the spine and muscles in the central part of the body. From the moment an embryo starts to ...